Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
نویسندگان
چکیده
منابع مشابه
Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
BACKGROUND The objective of this study is to assess the risk of second primary cancers following a first primary esophageal cancer as well as the risk of esophageal cancer as a second primary, following first primary cancers of other sites. METHODS The present investigation is a multicenter study of 13 population-based cancer registries in Europe, Australia, Canada, and Singapore. To assess e...
متن کاملAndrogen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies.
BACKGROUND While androgen deprivation therapy (ADT) is a common treatment for prostate cancer, little is known regarding its long-term health effects, particularly as it relates to the development of second primary malignancies. Therefore, the goal of this study was to assess the association between ADT use and second primary malignancies among men diagnosed with localized prostate cancer. ME...
متن کاملrisk factors of developing a second malignancy following treatment of a first primary breast cancer
abstract background: breast cancer is the most prevalent cancer among iranian women, and is the fifth cause of cancer-related death in iran. most studies have reported an overall excess of 20–30% chance for a second primary cancer to develop in individuals with a first breast cancer. in this study, we evaluated different factors might have a role in increasing the incidence of a second malignan...
متن کاملRe-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
PURPOSE For recurrent esophageal cancer after primary definitive radiotherapy, no general treatment guidelines are available. We evaluated the toxicities and clinical outcomes of re-irradiation (re-RT) for recurrent esophageal cancer. MATERIALS AND METHODS We analyzed 10 patients with recurrent esophageal cancer treated with re-RT after primary definitive radiotherapy. The median time interva...
متن کاملThe risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
BACKGROUND The 10-yr survival rate of patients with differentiated thyroid cancer exceeds 90%. These patients may be at elevated risk for secondary cancers. METHODS The risk of nonthyroid second primary malignancies after differentiated thyroid cancer was determined in 30,278 patients diagnosed between 1973 and 2002 from centers participating in the National Cancer Institute's Surveillance, E...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Medicine
سال: 2019
ISSN: 2045-7634,2045-7634
DOI: 10.1002/cam4.2688